4/25
04:38 pm
dsgn
Form ARS Design Therapeutics, For: Dec 31
Low
Report
Form ARS Design Therapeutics, For: Dec 31
4/25
04:34 pm
dsgn
Form DEFA14A Design Therapeutics,
Low
Report
Form DEFA14A Design Therapeutics,
4/25
04:32 pm
dsgn
Form DEF 14A Design Therapeutics, For: Jun 13
Low
Report
Form DEF 14A Design Therapeutics, For: Jun 13
3/25
07:11 pm
dsgn
Form 4 Design Therapeutics, For: Mar 22 Filed by: Schmid John P.
Medium
Report
Form 4 Design Therapeutics, For: Mar 22 Filed by: Schmid John P.
3/25
07:09 pm
dsgn
Form 4 Design Therapeutics, For: Mar 25 Filed by: Berger Heather A.
Medium
Report
Form 4 Design Therapeutics, For: Mar 25 Filed by: Berger Heather A.
3/20
07:58 pm
dsgn
Form 3 Design Therapeutics, For: Mar 13 Filed by: Kim Jae B.
High
Report
Form 3 Design Therapeutics, For: Mar 13 Filed by: Kim Jae B.
3/19
04:26 pm
dsgn
Form S-8 Design Therapeutics,
High
Report
Form S-8 Design Therapeutics,
3/19
04:19 pm
dsgn
Form 10-K Design Therapeutics, For: Dec 31
High
Report
Form 10-K Design Therapeutics, For: Dec 31
3/19
04:13 pm
dsgn
Form 8-K Design Therapeutics, For: Mar 19
High
Report
Form 8-K Design Therapeutics, For: Mar 19
2/14
04:59 pm
dsgn
Form SC 13G/A Design Therapeutics, Filed by: CITADEL ADVISORS LLC
Medium
Report
Form SC 13G/A Design Therapeutics, Filed by: CITADEL ADVISORS LLC
2/14
03:02 pm
dsgn
Form SC 13G/A Design Therapeutics, Filed by: Cormorant Asset Management, LP
Low
Report
Form SC 13G/A Design Therapeutics, Filed by: Cormorant Asset Management, LP